Department of Health and Human Services (DHHS)

National Institutes of Health (NIH)

Preliminary Workshop Agenda

Borderline Ovarian Tumor Consensus Workshop


NIH Office of Rare Diseases

NCI Office of Women's Health

NCI Cancer Diagnosis Program


Jules J. Berman, Ph.D., M.D.

Steven Silverberg, M.D.

Hyatt Regency Bethesda

Bethesda, Maryland

August 27-28, 2003

Wednesday, August 27, 2003

12:30 p.m.  Registration


1:00 p.m.   Welcome/Administrative Issues/Charge to Workshop

   Dr. Jules Berman

1:15  p.m.   Workshop Overview 

   Dr. Steven Silverberg


The purpose of each presentation is to focus the group on consensus issues and consensus strategies.  The presentations are not designed as subject reviews or as arguments in support of any viewpoint.

1:30 p.m.   Borderline Ovarian Tumors - Clinical Perspective

   Dr. Larry Copeland


2:00 p.m.    Borderline Ovarian Tumors - Molecular Biologist's


   Drs. Kathleen Cho, Michael Birrer

2:30 p.m.             Borderline Ovarian Tumors - Data/Study Design Perspective 

   Dr. Mark Sherman

2:45 p.m.             Open Discussion 

   Panel - Drs Copeland, Cho,  Birrer, Sherman 


3:05 p.m.   Break

3:15 p.m.             Micropapillary variant 

   Dr. Jeff Seidman

3:45 p.m.             Tumor implants  

   Drs. Robert Kurman and Debra Bell

4:40 p.m.   Open discussion

   Panel - Drs. Seidman, Kurman, Bell, Young, Silva

5:15 p.m.             Mucinous tumors

   Dr. Brigitte Ronnett

5:45 p.m.             Discussion/Questions

   Panel - Drs. Ronnett, Silverberg, Silva

6:00 p.m.             Adjournment for day 1

   Dr. Berman

Thursday, August 28, 2003

8:00 a.m.  Focus session  (Preliminary Consensus Items) 

                                    Drs. Young, Silva, Kurman, Silverberg, Seidman  


9:00 a.m.     Breakout Sessions

   Serous -  Dr. Steven Silverberg (leader)

   Mucinous - Dr. Brigette Ronnett (leader)

10:00   Break/Hotel Check-Out


10:30   Breakout Sessions Continue

Noon   Working Lunch 


1:30 p.m.   Presentations from Breakout Session Leaders with open


   (Drs Silverberg and Ronnett, with Dr. Robert Young, moderator)

2:30 p.m.         Publication plans (with Dr. Fred Gorstein)

   Final review of day's accomplishments (Dr. Jules Berman)

3:00 p.m.  Travel announcements and adjournment

   Dr. Jules Berman

key words: lmp, bot, ovarian cancer, ovarian carcinoma, benign, nci, nih, gynecology, gyn pathology, cancer research, cancer diagnosis, overtreatment, treatment, metastasis, implantation, ovary, ovaries, epithelial
Contact person: Dr. Jules Berman, Jules J. Berman,
Date: August 27, 28, 2003
Link to Workshop summary: pending